Individuals Coming Off Weight-Loss Medications Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis reveals that patients who discontinue new slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt conventional diet and exercise programs.

Published data in a major health publication points out that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month once they quit.

"Individuals buying these medications should be cognizant of the risk of quick rebound weight gain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to pre-treatment weight in about one and a half years.

Analyzing Treatments

The study, which looked at 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.

Researchers note that individuals who shed pounds through dieting typically have a more gradual weight regain—around 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Nutrition scientists propose the mode of action of the injections is key to understanding the accelerated weight return.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of the hormone levels several times higher than normal could lead to the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication results in hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Disease?

Health authorities advise the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, given the high risk of weight regain, the therapy is often long-term.

This view is supported by pharmaceutical companies, who say that the results "emphasize the long-term nature of obesity," similar to managing conditions like hypertension.

User Accounts

Users who have discontinued the medication explain a powerful resurgence of hunger.

"It felt as if something flipping and you're instantly ravenous," described a patient.

This challenge is worsened if users have not developed sustainable lifestyle or habit modifications during treatment.

Significant Use

Survey data show that millions of people in the UK have used these injections in the past year, with demand continuing to grow.

• Use is higher among women compared to men.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Finally, experts stress that while these medications are potent tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on ongoing lifestyle management.